Here are five notes:
1. The shares were sold at an average price of $22.37, for a total of $12.8 million.
2. After the transaction, the director now owns 440 shares of the company’s stock, valued at approximately $9,842.
3. K2M has a 52-week low of $12.31 and a 52-week high of $26.29.
4. The stock has a 50-day moving average of $24.40 and a 200-day moving average of $22.23.
5. The company’s market cap is $954.50 million.
More articles on devices:
NuVasive names new executive vice president — 5 key notes
J&J Orthopedics sales drop 5.6% in Q2: 5 key notes
Surgical Science features Zyga’s SImmetry SI joint fusion system: 5 key notes
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
